| Literature DB >> 17565692 |
Anne N Nafziger1, Kristina Lindvall, Margareta Norberg, Hans Stenlund, Stig Wall, Paul L Jenkins, Thomas A Pearson, Lars Weinehall.
Abstract
BACKGROUND: Obesity has primarily been addressed with interventions to promote weight loss and these have been largely unsuccessful. Primary prevention of obesity through support of weight maintenance may be a preferable strategy although to date this has not been the main focus of public health interventions. The aim of this study is to characterize who is not gaining weight during a 10 year period in Sweden.Entities:
Mesh:
Year: 2007 PMID: 17565692 PMCID: PMC1904206 DOI: 10.1186/1471-2458-7-108
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Figure 1Västerbotten Intervention Programme longitudinal study participants according to body mass index and weight change category.
Figure 2Västerbotten Intervention Programme study design showing survey years, age and number of participants, and cross-sectional and longitudinal study populations.
Figure 3Prevalence of obesity among men participating in the Västerbotten Intervention Programme cross-sectional studies between 1990 and 2004. 30 year olds were not surveyed after 1995.
Figure 4Prevalence of obesity among women participating in the Västerbotten Intervention Programme cross-sectional studies between 1990 and 2004. 30 year olds were not surveyed after 1995.
Comparison of baseline characteristics for participants and non-participants in the 10-year longitudinal study within the Västerbotten Intervention Programme surveys, 1990–1994.1
| Baseline characteristic | Participants (%) | Non-participants (%) | |
| Age (years) | 30 | 23.4% | 29.9%§ |
| 40 | 39.7% | 39.3% | |
| 50 | 36.9% | 30.8% | |
| Sex | Male | 46.6% | 50.4%§ |
| Female | 53.4% | 49.6% | |
| Education | Low | 22.8% | 21.8%† |
| Medium | 53.9% | 52.6% | |
| High | 23.4% | 25.6% | |
| Body mass index, kg/m2 | 24.8 (3.8) | 25.2 (4.1) | |
| Serum cholesterol, mean (SD) mmol/L | 5.49 (1.20) | 5.52 (1.23)* | |
| Blood pressure, mean (SD) mmHg | Systolic | 123 (15) | 124 (15) |
| Diastolic | 77 (10) | 77 (11) | |
| Glucose metabolism | Normal | 93.2% | 92.6%† |
| Glucose intolerance | 4.0% | 3.6% | |
| Diabetes | 2.8% | 3.7% | |
| Smoker | 24.8% | 30.4%§ | |
| Snuff use | 25.6% | 28.7%§ | |
| Physically inactive | 41.5% | 42.9%† | |
1This table includes only those eligible for the longitudinal study. *differed by p < 0.05 between participants and non-participants; †differed by <0.01 between participants and non-participants; §differed by <0.001 between participants and non-participants
Baseline and 10-year follow up characteristics of men and women in the Västerbotten Intervention Programme longitudinal study, 1990–2004, by weight gain or non-gain status.1
| Number (%) | 2569 (36.4) | 4487 (63.6) | 2673 (34.2) | 5138 (65.8) | |
| BMI (kg/m2) | Baseline | 25.1 ± 2.4 | 24.5 ± 2.5 | 23.9 ± 2.6 | 23.5 ± 2.6 |
| 10-year follow-up | 24.9 ± 2.7 | 26.8 ± 3.1 | 23.4 ± 2.7 | 26.2 ± 3.6 | |
| Weight (kg) | Baseline | 79.7 ± 9.1 | 78.3 ± 9.3 | 65.2 ± 8.2 | 64.0 ± 8.0 |
| 10-year follow-up | 78.7 ± 9.1 | 85.6 ± 10.8 | 63.6 ± 8.1 | 71.3 ± 10.1 | |
| Civil status (%) | Single | 13.2 | 13.2 | 6.1 | 6.9 |
| Married | 81.9 | 80.9 | 85.9 | 84.1 | |
| Widowed | 0.4 | 0.4 | 1.3 | 1.2 | |
| Divorced or separated | 3.4 | 4.2 | 5.3 | 6.6 | |
| Remarried | 1.0 | 1.3 | 1.4 | 1.1 | |
| Education (%) | Low | 28.0 | 21.9 | 25.2 | 22.3 |
| Medium | 50.6 | 57.2 | 46.9 | 49.2 | |
| High | 22.3 | 18.7 | 26.1 | 27.0 | |
| Serum cholesterol, mmol/L | 5.3 ± 4.0 | 5.5 ± 1.2 | 5.5 ± 1.1 | 5.3 ± 1.1 | |
| Heart disease (%) | 4.3 | 4.0 | 2.5 | 2.0 | |
| Use of medicine for heart disease (%) | 3.3 | 3.2 | 2.5 | 2.0 | |
| Family history of CV disease (%) | 17.0 | 16.6 | 17.5 | 18.3 | |
| Hypertension (%) | 28.5 | 21.2 | 19.8 | 17.2 | |
| Snuff use (%) | 21.8 | 26.3 | 2.4 | 3.5 | |
| Glucose metabolism (%) | Normal | 95.5 | 97.5 | 93.7 | 95.2 |
| Glucose intolerance2 | 3.1 | 1.9 | 5.0 | 1.4 | |
| Diabetes type 23 | 1.4 | 0.7 | 1.3 | 0.7 | |
| Family history of diabetes (%) | 15.0 | 13.2 | 16.7 | 16.3 | |
Data are presented as mean (± SD) unless otherwise noted. 1Non-gain was defined as weight loss or maintenance of body weight within 3% of baseline weight. Gain was defined as an increase in weight of ≥3%.
Figure 5Proportion of men maintaining weight in the Västerbotten Intervention Programme longitudinal studies between 1990 and 2004 by age group.
Figure 6Proportion of women maintaining weight in the Västerbotten Intervention Programme longitudinal studies between 1990 and 2004 by age group.
Odds ratios for univariate analyses of baseline characteristics and 10-year weight non-gain.1
| Baseline Characteristic | Odds ratio2 | (95% CI) | |
| Men | 30 yr | 1.0 | |
| 40 yr | 1.14 | (1.00–1.30) | |
| 50 yr | 2.36 | (2.08–2.68) | |
| Women3 | 30 yr | 1.17 | (1.02–1.35) |
| 40 yr | 1.18 | (1.04–1.34) | |
| 50 yr | 1.59 | (1.40–1.80) | |
| Civil status | Single | 1.0 | |
| Married | 1.04 | (0.93–1.16) | |
| Widowed | 1.11 | (0.77–1.60) | |
| Divorced or separated | 0.82 | (0.68–0.98) | |
| Remarried | 1.00 | (.073–1.38) | |
| Education | High | 1.0 | |
| Medium | 0.93 | (0.86–1.01) | |
| Low | 1.22 | (1.11–1.34) | |
| Baseline BMI | 18.5–24.9 | 1.0 | |
| 25.0–29.9 | 1.27 | (1.21–1.34) | |
| Survey year | 1990 | 1.0 | |
| 1991 | 1.23 | (1.08–1.39) | |
| 1992 | 1.39 | (1.23–1.57) | |
| 1993 | 1.44 | (1.27–1.62) | |
| 1994 | 1.71 | (1.52–1.93) | |
| Serum cholesterol, mmol/L | 1.14 | (1.10–1.17) | |
| Heart disease | No | 1.0 | |
| Yes | 1.15 | (0.96–1.38) | |
| Use of medicine for heart disease | No | 1.0 | |
| Yes | 1.12 | (0.92–1.37) | |
| Family history of CV disease | No | 1.0 | |
| Yes | 0.98 | (0.90–1.07) | |
| Hypertension | No | 1.0 | |
| Yes | 1.35 | (1.24–1.46) | |
| Cigarette smoker | No | 1.0 | |
| Yes | 0.99 | (0.92–1.05) | |
| Snuff use | No | 1.0 | |
| Yes | 0.82 | (0.74–0.91) | |
| Glucose metabolism | Normal | 1.0 | |
| Glucose intolerance4 | 1.35 | (1.13–1.60) | |
| Diabetes type 25 | 2.05 | (1.47–2.85) | |
| Family history of diabetes | No | 1.0 | |
| Yes | 1.04 | (0.94–1.13) | |
1Weight non-gain included individuals who lost weight and those who maintained their body weight within 3% of the baseline weight. 2Using a logistic regression model with weight gain of >3% body weight versus no weight gain. 3A six-level age-sex variable was created, using 30 year old men as the reference group. 4Fasting glucose <7.0 mmol/L and 2-hour capillary plasma glucose after a 75 g glucose load (oral glucose tolerance test) ≥ 8.9 to <12.2 mmol/L and without diagnosis of diabetes type 2 [21]. 5Diabetes mellitus defined as self-report, fasting blood glucose of ≥7.0 mmol/L, or 2-hour capillary plasma glucose (oral glucose tolerance test) of ≥12.2 mmol/L [21].
Odds ratios for the multivariate model of baseline characteristics and 10-year weight non-gain.1
| Baseline Characteristic | Number | Odds Ratio (95% CI)2 | |
| Men | 30 yr | 1726 | 1.00 |
| 40 yr | 835 | 1.13 (0.99, 1.30) | |
| 50 yr | 2495 | 2.24 (1.96, 2.56) | |
| Women3 | 30 yr | 1787 | 1.14 (0.98, 1.32) |
| 40 yr | 3152 | 1.17 (1.03, 1.35) | |
| 50 yr | 2872 | 1.50 (1.16, 1.34) | |
| Body mass index (kg/m2) | 18.5–24.9 | 9412 | 1.00 |
| 25–29.9 | 5455 | 1.25 (1.16, 1.34) | |
| Year of initial survey | 1990 | 1802 | 1.00 |
| 1991 | 2724 | 1.19 (1.04, 1.36) | |
| 1992 | 3465 | 1.38 (1.21, 1.56) | |
| 1993 | 3648 | 1.43 (1.26, 1.62) | |
| 1994 | 3228 | 1.74 (1.53, 1.98) | |
| Glucose metabolism | Normal | 14238 | 1.00 |
| Glucose intolerance4 | 452 | 1.15 (0.94, 1.40) | |
| Type 2 diabetes5 | 177 | 1.47 (1.08, 1.99) | |
| Snuff use | No | 12888 | 1.00 |
| Yes | 1977 | 0.83 (0.74, 0.92) | |
1Weight non-gain included individuals who lost weight and those who maintained their body weight within 3% of the baseline weight. 2Using a logistic regression model with weight gain of >3% body weight versus no weight gain. The model showed goodness-of-fit by Hosmer-Lemeshow test. There were no main effect interactions. 3A six-level age-sex variable was created, using 30 year old men as the reference group.4Fasting glucose <7.0 mmol/L and 2-hour capillary plasma glucose after a 75 g glucose load (oral glucose tolerance test) ≥ 8.9 to <12.2 mmol/L and without diagnosis of diabetes type 2 [21]. 5Diabetes mellitus defined as self-report, fasting blood glucose of ≥7.0 mmol/L, or 2-hour capillary plasma glucose (oral glucose tolerance test) of ≥12.2 mmol/L [21].